Kick In The Liver For Schering - Forbes

by Business News

Business Wire (press release)

Kick In The Liver For Schering Forbes - 1 hour ago Vertex Pharmaceuticals said Monday it would release positive results from a mid-stage study for its hepatitis C drug, a major competitor of Schering's upcoming hepatitis C treatment boceprevir. Clinical results boost Vertex Boston Globe Shares of Vertex Increase On Data for Hepatitis Drug Wall Street Journal CNNMoney.com - FOXBusiness - CanadianBusiness.com all 19 news articles

0 comments

There are no comments yet...

Kick things off by filling out the form below.

You must log in to post a comment.